Casdin Capital, LLC Q4 2016 Filing
Filed February 14, 2017
Portfolio Value
$121.1B
Holdings
25
Report Date
Q4 2016
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SG7SAGE THERAPEUTICS INC | 259,500 | $13.3B | 10.94% | |
| 2 | —LOXO ONCOLOGY INC | 360,000 | $11.6B | 9.55% | |
| 3 | AGIOAGIOS PHARMACEUTICALS INC | 240,500 | $10.0B | 8.29% | |
| 4 | —FOUNDATION MEDICINE INC | 546,000 | $9.7B | 7.98% | |
| 5 | EVHEVOLENT HEALTH INC | 555,000 | $8.2B | 6.78% | |
| 6 | 2L9BLUEPRINT MEDICINES CORP | 244,500 | $6.9B | 5.66% | |
| 7 | —SPARK THERAPEUTICS INC | 128,500 | $6.4B | 5.30% | |
| 8 | —GENMARK DIAGNOSTICS INC | 510,000 | $6.2B | 5.16% | |
| 9 | —BLUEBIRD BIO INC | 82,500 | $5.1B | 4.20% | |
| 10 | VYGRVOYAGER THERAPEUTICS INC | 385,000 | $4.9B | 4.05% | |
| 11 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 304,000 | $4.4B | 3.63% | |
| 12 | —KITE PHARMA INC | 94,000 | $4.2B | 3.48% | |
| 13 | —MYOKARDIA INC | 265,000 | $3.4B | 2.83% | |
| 14 | —EPIZYME INC | 275,000 | $3.3B | 2.75% | |
| 15 | ILMNILLUMINA INC | 25,000 | $3.2B | 2.64% | |
| 16 | ALNYALNYLAM PHARMACEUTICALS INC | 85,000 | $3.2B | 2.63% | |
| 17 | CERNCHFCERNER CORP | 65,000 | $3.1B | 2.54% | |
| 18 | MDRXALLSCRIPTS HEALTHCARE SOLUTN | 280,000 | $2.9B | 2.36% | |
| 19 | —AMYRIS INC | 3,425,000 | $2.5B | 2.06% | |
| 20 | —SYROS PHARMACEUTICALS INC | 182,141 | $2.2B | 1.83% | |
| 21 | —AEVI GENOMIC MEDICINE INC | 375,000 | $1.9B | 1.60% | |
| 22 | CTMXCYTOMX THERAPEUTICS INC | 127,500 | $1.4B | 1.16% | |
| 23 | XLRNACCELERON PHARMA INC | 45,000 | $1.1B | 0.95% | |
| 24 | EDITEDITAS MEDICINE INC | 65,000 | $1.1B | 0.87% | |
| 25 | GILDGILEAD SCIENCES INC | 12,500 | $895.0M | 0.74% |